|

Ex-Nigerian Minister Backs Out Of Board of Top Global Health Initiative

Muhammad Ali Pate, a Harvard professor who has held top health jobs in Nigeria, has relinquished the top job at...

Muhammad Ali Pate, a Harvard professor who has held top health jobs in Nigeria, has relinquished the top job at the Gavi global vaccine alliance, the organisation announced Monday.

Pate, a medical doctor trained in internal medicine and infectious disease, was due to assume the helm on August 3, Gavi had announced in February, taking over from US medical epidemiologist Seth Berkley, who had been in charge since 2011.

Pate informed Gavi “that he has taken an incredibly difficult decision to accept a request to return and contribute to his home country, Nigeria,” the statement said, without further details about the decision.

Gavi’s Chief Operating Officer David Marlow will instead assume the position of Interim Chief Executive Officer while a search for a new CEO continues.

The Gavi vaccine alliance is a non-profit organisation created in 2000 to provide an array of vaccines to developing countries.

It says that since its inception, it has provided vaccines to more than 981 million children, “and prevented more than 16.2 million future deaths, helping to halve child mortality in 73 lower-income countries.”

Gavi has taken the lead on the Covax initiative, alongside the World Health Organization and the Coalition for Epidemic Preparedness Innovations.

The global scheme has so far shipped nearly 1.9 billion Covid vaccines to 146 territories, with the focus on providing donor-funded jabs to the 92 weakest economies.

AFP

Leave a Reply

Your email address will not be published. Required fields are marked *

Sign up for the HB Newsletter

Get stories that matter delivered directly to your inbox

OTHER STORIES

Get the stories that matter most delivered directly to your inbox

© Copyright 2025 – HB Report. All Rights Reserved

HB Logo

Sign up for the HB newsletter

By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.